Skip to main content
. 2018 Nov 1;17(1):1019–1029. doi: 10.3892/ol.2018.9656

Figure 7.

Figure 7.

Prognostic impact of galectins for survival of patients with CLL. Kaplan-Meier survival curves of patients with CLL, depicting survival based on (A) galectin-1, (B) galectin-9, (C) galectin-3 and (D) galectin 3-binding protein concentration. Patients were divided into two groups according to whether their galectin levels were above (0) or below (1) the 75th percentile. Tick marks indicate patients who were alive at last follow-up. Follow-up time is presented in months following chemotherapy treatment. CLL, chronic lymphocytic leukemia.